2.4.0.6 Html 112 225 1 false 52 0 false 7 false false R1.htm 101 - Document - Document and Entity Information Sheet http://www.cytosorbents.com/taxonomy/role/DocumentDocumentandEntityInformation Document and Entity Information true false R2.htm 103 - Statement - CONSOLIDATED BALANCE SHEETS Sheet http://www.cytosorbents.com/taxonomy/role/StatementOfFinancialPositionClassified CONSOLIDATED BALANCE SHEETS false false R3.htm 104 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://www.cytosorbents.com/taxonomy/role/StatementOfFinancialPositionClassifiedParenthetical CONSOLIDATED BALANCE SHEETS (Parenthetical) false false R4.htm 105 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS Sheet http://www.cytosorbents.com/taxonomy/role/StatementOfIncome CONSOLIDATED STATEMENTS OF OPERATIONS false false R5.htm 106 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) Sheet http://www.cytosorbents.com/taxonomy/role/StatementOfShareholdersEquityAndOtherComprehensiveIncome CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) false false R6.htm 107 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.cytosorbents.com/taxonomy/role/StatementOfCashFlowsIndirect CONSOLIDATED STATEMENTS OF CASH FLOWS false false R7.htm 108 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical) Sheet http://www.cytosorbents.com/taxonomy/role/StatementOfCashFlowsIndirectParenthetical CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical) false false R8.htm 109 - Disclosure - BASIS OF PRESENTATION Sheet http://www.cytosorbents.com/taxonomy/role/NotesToFinancialStatementsBasisOfAccounting BASIS OF PRESENTATION false false R9.htm 110 - Disclosure - PRINCIPAL BUSINESS ACTIVITY AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://www.cytosorbents.com/taxonomy/role/NotesToFinancialStatementsOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock PRINCIPAL BUSINESS ACTIVITY AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES false false R10.htm 111 - Disclosure - CONVERTIBLE NOTES Notes http://www.cytosorbents.com/taxonomy/role/NotesToFinancialStatementsDebtDisclosureTextBlock CONVERTIBLE NOTES false false R11.htm 112 - Disclosure - STOCKHOLDERS' EQUITY (DEFICIT) Sheet http://www.cytosorbents.com/taxonomy/role/NotesToFinancialStatementsStockholdersEquityNoteDisclosureTextBlock STOCKHOLDERS' EQUITY (DEFICIT) false false R12.htm 113 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://www.cytosorbents.com/taxonomy/role/NotesToFinancialStatementsCommitmentsAndContingenciesDisclosureTextBlock COMMITMENTS AND CONTINGENCIES false false R13.htm 114 - Disclosure - NET LOSS PER SHARE Sheet http://www.cytosorbents.com/taxonomy/role/NotesToFinancialStatementsEarningsPerShareTextBlock NET LOSS PER SHARE false false R14.htm 115 - Disclosure - SUBSEQUENT EVENTS Sheet http://www.cytosorbents.com/taxonomy/role/NotesToFinancialStatementsSubsequentEventsTextBlock SUBSEQUENT EVENTS false false R15.htm 116 - Disclosure - PRINCIPAL BUSINESS ACTIVITY AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://www.cytosorbents.com/taxonomy/role/NotesToFinancialStatementsOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlockPolicies PRINCIPAL BUSINESS ACTIVITY AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) false false R16.htm 117 - Disclosure - STOCKHOLDERS' EQUITY (DEFICIT) (Tables) Sheet http://www.cytosorbents.com/taxonomy/role/NotesToFinancialStatementsStockholdersEquityNoteDisclosureTextBlockTables STOCKHOLDERS' EQUITY (DEFICIT) (Tables) false false R17.htm 118 - Disclosure - BASIS OF PRESENTATION - Additional Information (Detail) Sheet http://www.cytosorbents.com/taxonomy/role/DisclosureBASISOFPRESENTATIONAdditionalInformation BASIS OF PRESENTATION - Additional Information (Detail) false false R18.htm 119 - Disclosure - PRINCIPAL BUSINESS ACTIVITY AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Detail) Sheet http://www.cytosorbents.com/taxonomy/role/DisclosurePRINCIPALBUSINESSACTIVITYANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformation PRINCIPAL BUSINESS ACTIVITY AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Detail) false false R19.htm 120 - Disclosure - CONVERTIBLE NOTES - Additional Information (Detail) Notes http://www.cytosorbents.com/taxonomy/role/DisclosureCONVERTIBLENOTESAdditionalInformation CONVERTIBLE NOTES - Additional Information (Detail) false false R20.htm 121 - Disclosure - STOCKHOLDERS' EQUITY (DEFICIT) - Additional Information (Detail) Sheet http://www.cytosorbents.com/taxonomy/role/DisclosureSTOCKHOLDERSEQUITYDEFICITAdditionalInformation STOCKHOLDERS' EQUITY (DEFICIT) - Additional Information (Detail) false false R21.htm 122 - Disclosure - Summary of Stock Option Activity (Detail) Sheet http://www.cytosorbents.com/taxonomy/role/DisclosureSummaryOfStockOptionActivity Summary of Stock Option Activity (Detail) false false R22.htm 123 - Disclosure - Summary of Status of Non-Vested Options (Detail) Sheet http://www.cytosorbents.com/taxonomy/role/DisclosureSummaryOfStatusOfNonVestedOptions Summary of Status of Non-Vested Options (Detail) false false R23.htm 124 - Disclosure - Warrants to Purchase Common Stock (Detail) Sheet http://www.cytosorbents.com/taxonomy/role/DisclosureWarrantsToPurchaseCommonStock Warrants to Purchase Common Stock (Detail) false false R24.htm 125 - Disclosure - COMMITMENTS AND CONTINGENCIES - Additional Information (Detail) Sheet http://www.cytosorbents.com/taxonomy/role/DisclosureCOMMITMENTSANDCONTINGENCIESAdditionalInformation COMMITMENTS AND CONTINGENCIES - Additional Information (Detail) false false R25.htm 126 - Disclosure - NET LOSS PER SHARE - Additional Information (Detail) Sheet http://www.cytosorbents.com/taxonomy/role/DisclosureNETLOSSPERSHAREAdditionalInformation NET LOSS PER SHARE - Additional Information (Detail) false false R26.htm 127 - Disclosure - SUBSEQUENT EVENTS - Additional Information (Detail) Sheet http://www.cytosorbents.com/taxonomy/role/DisclosureSUBSEQUENTEVENTSAdditionalInformation SUBSEQUENT EVENTS - Additional Information (Detail) false false All Reports Book All Reports Element ctso_DividendsPreferredStockStockShares had a mix of decimals attribute values: 0 2. Element us-gaap_DividendsPreferredStockStock had a mix of decimals attribute values: 0 2. Element us-gaap_EquityIssuancePerShareAmount had a mix of decimals attribute values: 2 3. 'Monetary' elements on report '125 - Disclosure - COMMITMENTS AND CONTINGENCIES - Additional Information (Detail)' had a mix of different decimal attribute values. Process Flow-Through: 103 - Statement - CONSOLIDATED BALANCE SHEETS Process Flow-Through: Removing column 'Jun. 30, 2011' Process Flow-Through: Removing column 'Dec. 31, 2010' Process Flow-Through: 104 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) Process Flow-Through: 105 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS Process Flow-Through: 107 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS Process Flow-Through: 108 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical) ctso-20120630.xml ctso-20120630.xsd ctso-20120630_cal.xml ctso-20120630_def.xml ctso-20120630_lab.xml ctso-20120630_pre.xml true true